# Bal Pharma Ltd (BALPHARMA)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹82.03
Day Change: -3.64%
52W High: ₹112.97
52W Low: ₹59.69
Market Cap: ₹126 Cr

## Valuation
P/E: 15.51
P/B: 1.59
EPS: ₹5.09
Book Value: ₹49.68
Dividend Yield: 0%

## Returns
1Y Return: -1.43%

## Profitability
ROE: 0%
ROCE: 10.37%
Debt/Equity: 1.98
Revenue Growth: 19.9%
Profit Growth: 239.4%
EBITDA Margin: 7.78%
Operating Margin: 7.2%

## About
Bal Pharma Ltd is a Drug Manufacturers - Specialty & Generic company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Drug Manufacturers - Specialty & Generic
Sub Industry: Unknown

## Business Model
Overview: Bal Pharma Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Drug Manufacturers - Specialty & Generic. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
- Announcement: Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- BSE Filing: Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-05-24T20:00:00.755Z
Price History Updated: 2026-05-17T21:24:37.474Z
Latest Price History Date: 2026-05-17
Technicals Updated: 2026-05-17T21:24:37.474Z
Quant Updated: 2026-05-17T21:24:37.474Z
Sentiment Updated: 2026-05-17T21:24:37.474Z
Financials Status: current
Financials Updated: 2026-05-18T23:05:36.687Z
Financials Last Attempt: 2026-05-18T23:05:36.687Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2015)
Revenue: ₹179 Cr
Operating Profit: ₹18 Cr (OPM 10%)
Net Profit: ₹5 Cr
Tax: ₹7 Cr

## Annual P&L History
Mar 2015: Rev ₹179Cr | PAT ₹5Cr | OPM 10%
Mar 2016: Rev ₹187Cr | PAT ₹4Cr | OPM 9%
Mar 2017: Rev ₹198Cr | PAT ₹1Cr | OPM 7%

## Balance Sheet (Mar 2015)
Total Assets: ₹155 Cr
Total Liabilities: ₹155 Cr
Borrowings: ₹51 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Shailesh Dheerajmal Siroya, MD & Executive Director
- Daddanala Venkat Bharath Bhushan, Chief Financial Officer
- Archana Dubey Mitra, Chief Operating Officer
- Abdul  Basith, Company Secretary & Compliance Officer
- Himesh  Virupakshaya, Whole Time Director

---
Source: rupiya.io/stocks/balpharma
Disclaimer: For research and education only. Not investment advice.